Influence of Sleep Quality in Patients With Periorbicular Hyperchromia
NCT03393624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302
Last updated 2020-02-12
Summary
Periorbital hyperchromia (POH) or periorbital hyperpigmentation, commonly known as "dark circles", is a relatively common condition and a frequent reason for dermatological consultation. It is defined as brown-colored pigmentation, ranging from light to dark, which mainly involves the lower eyelids. POH affects individuals over a wide age range, including both sexes and all ethnicities, and is associated with a tired and aged facial appearance. The most commonly affected people are those with the highest skin phototypes. Although the prevalence is similar between sexes and age groups, POH is a more frequent complaint in women. The dark circles characteristic of POH can negatively impact patients' quality of life, although it is not a condition associated with morbidity. Popularly it is believed that the poor quality of sleep is a factor responsible for its appearance, but there is no consistent data in the literature that prove this.
Conditions
- Periorbital Disorder
Sponsors & Collaborators
-
Hospital de Clinicas de Porto Alegre
lead OTHER
Principal Investigators
-
Juliana C Boza, PhD · Hospital de Clínicas de Porto Alegre
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2020-02-10
- Completion
- 2020-02-10
Countries
- Brazil
Study Locations
More Related Trials
-
Epidemiology of Sleep Disturbances Among the Adult Population of the Sao Paulo City
NCT00596713 ·Status: COMPLETED
-
To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.
NCT00346554 ·Status: COMPLETED
-
Effects of Afternoon and Evening Light on Teenagers' Melatonin Levels, Alertness, Sleepiness and Sleep
NCT05483296 ·Status: COMPLETED ·Phase: NA
-
Aging, Sleep, Cognitive Process
NCT00804804 ·Status: COMPLETED ·Phase: NA
-
The Association Between Sleep Duration and Sleep Disorders and Proteinuria in Children
NCT03933046 ·Status: UNKNOWN ·Phase: NA
-
Impact of Sleep Disorders and Digital Support on Older People's Health
NCT06944600 ·Status: NOT_YET_RECRUITING
-
Sleep Disturbances in Dermatology Patients
NCT03903263 ·Status: COMPLETED
-
Chronic Sleep Restriction and Driving
NCT00560456 ·Status: COMPLETED ·Phase: NA
-
Local Sleep in Idiopathic Hypersomnia
NCT06153615 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sleep Hygiene Intervention on Sleep Quality Improvement in Elders With Parkinson's Disease
NCT06937632 ·Status: COMPLETED ·Phase: NA
-
Sleep Disorders After TIPS
NCT03685994 ·Status: UNKNOWN
-
Prevalence of Sleep Disturbances in Elderly People Hospitalized in Medicine, Psychiatry and Rehabilitation Departments: TOPASE Prospective Study, RIPH 3
NCT06659575 ·Status: COMPLETED
-
Constitution of a Clinical, Neurophysiological and Biological Cohort for Chronic Sleep Disorders Responsible of Hypersomnolence
NCT03998020 ·Status: RECRUITING ·Phase: NA
-
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
NCT01586039 ·Status: COMPLETED ·Phase: NA
-
Chronic Sleep Restriction
NCT01493661 ·Status: COMPLETED
-
Neurocognition After Perturbed Sleep
NCT05032963 ·Status: COMPLETED ·Phase: NA
-
Characterization of Children with Complaints of Excessive Daytime Sleepiness
NCT06898008 ·Status: COMPLETED
-
Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease
NCT06294964 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Sleep, Cognition and Memory Disorder
NCT01650454 ·Status: COMPLETED ·Phase: NA
-
The SLEEP-CARE Study
NCT06336408 ·Status: RECRUITING
-
Managing Sleep-wake Disruption Due to Hospitalisation: the Circadian Care Project
NCT05228444 ·Status: UNKNOWN ·Phase: NA
-
The Peripheral Blood Multi-Omics Study on Sleep Loss
NCT06492109 ·Status: RECRUITING ·Phase: NA
-
Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU
NCT06346613 ·Status: RECRUITING
-
Sleep Disruption Induced Impairments in Bone Formation
NCT03733483 ·Status: COMPLETED ·Phase: NA
-
Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea
NCT03299257 ·Status: UNKNOWN ·Phase: PHASE4